A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs.
Betacoronavirus
/ isolation & purification
COVID-19
COVID-19 Testing
COVID-19 Vaccines
Clinical Laboratory Techniques
/ methods
Coronavirus Infections
/ diagnosis
Humans
Machine Learning
Mass Screening
/ methods
Multivariate Analysis
Nasopharynx
/ virology
Pandemics
Pneumonia, Viral
/ diagnosis
Real-Time Polymerase Chain Reaction
SARS-CoV-2
Sensitivity and Specificity
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
/ methods
COVID-19
MALDI-TOF
Machine learning
Mass spectrometry
SARS-CoV-2
Journal
Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
08
05
2020
revised:
06
10
2020
accepted:
06
10
2020
pubmed:
13
10
2020
medline:
1
12
2020
entrez:
12
10
2020
Statut:
ppublish
Résumé
Coronavirus disease 2019, known as COVID-19, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The early, sensitive and specific detection of SARS-CoV-2 virus is widely recognized as the critical point in responding to the ongoing outbreak. Currently, the diagnosis is based on molecular real time RT-PCR techniques, although their implementation is being threatened due to the extraordinary demand for supplies worldwide. That is why the development of alternative and / or complementary tests becomes so relevant. Here, we exploit the potential of mass spectrometry technology combined with machine learning algorithms, for the detection of COVID-19 positive and negative protein profiles directly from nasopharyngeal swabs samples. According to the preliminary results obtained, accuracy = 67.66 %, sensitivity = 61.76 %, specificity = 71.72 %, and although these parameters still need to be improved to be used as a screening technique, mass spectrometry-based methods coupled with multivariate analysis showed that it is an interesting tool that deserves to be explored as a complementary diagnostic approach due to the low cost and fast performance. However, further steps, such as the analysis of a large number of samples, should be taken in consideration to determine the applicability of the method developed.
Identifiants
pubmed: 33045283
pii: S0166-0934(20)30243-3
doi: 10.1016/j.jviromet.2020.113991
pmc: PMC7546642
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113991Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Références
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
PeerJ. 2018 Nov 07;6:e5784
pubmed: 30425884
Annu Rev Virol. 2016 Sep 29;3(1):237-261
pubmed: 27578435
FEMS Microbiol Rev. 2012 Mar;36(2):380-407
pubmed: 22092265
PLoS One. 2020 Mar 13;15(3):e0230334
pubmed: 32168352
Pharmacogenomics. 2003 Jul;4(4):463-76
pubmed: 12831324
Sci Rep. 2015 Jul 02;5:11805
pubmed: 26133466
J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32132196
J Clin Microbiol. 2013 Nov;51(11):3711-6
pubmed: 23985919
J Med Virol. 2020 Sep;92(9):1518-1524
pubmed: 32104917
Lancet Microbe. 2020 May;1(1):e10
pubmed: 32835322
Front Med. 2020 Apr;14(2):126-135
pubmed: 32240462
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Clin Microbiol Infect. 2016 Feb;22(2):161.e1-161.e7
pubmed: 26482268
Rev Argent Microbiol. 2019 Jul - Sep;51(3):255-258
pubmed: 30558855